Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

532
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
532
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

801
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
801
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital twins to accelerate target identification and drug development for immune-mediated disorders.

FEBS open bio·2026
Same author

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Annals of the rheumatic diseases·2025
Same author

Identifying Therapeutic Targets for Amyotrophic Lateral Sclerosis Through Modeling of Multi-Omics Data.

International journal of molecular sciences·2025
Same author

Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.

The FEBS journal·2025
Same author

Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort.

PloS one·2025
Same author

Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

Annals of the rheumatic diseases·2025

Related Experiment Video

Updated: Jul 28, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K

Artificial intelligence-driven drug development against autoimmune diseases.

Philippe Moingeon1

  • 1Research and Development, Servier Laboratories, 50 Rue Carnot, 92150 Suresnes, France; French Academy of Pharmacy, 4 Avenue de l'Observatoire, 75006 Paris, France.

Trends in Pharmacological Sciences
|June 2, 2023
PubMed
Summary
This summary is machine-generated.

Artificial intelligence models are advancing precision medicine for autoimmune and autoinflammatory disorders (AIIDs). These AI tools stratify patients and personalize treatments by analyzing molecular data and predicting drug efficacy.

Keywords:
artificial intelligenceautoimmune diseasesbiomarkercomputational precision medicinedrug development

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Related Experiment Videos

Last Updated: Jul 28, 2025

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

8.8K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Immunology

Background:

  • Precision medicine aims to tailor treatments for complex chronic diseases like autoimmune and autoinflammatory disorders (AIIDs).
  • Recent advancements utilize artificial intelligence (AI) and omic technologies to model AIIDs, revealing complex pathophysiology and shared molecular pathways.
  • Existing models focus on systemic lupus erythematosus (SLE), primary Sjögren syndrome (pSS), and rheumatoid arthritis (RA).

Purpose of the Study:

  • To review the application of AI-based predictive models in understanding and managing AIIDs.
  • To highlight how these models integrate molecular data for personalized treatment strategies.
  • To discuss the potential of AI in drug discovery and efficacy prediction for AIIDs.

Main Methods:

  • Development of AI-based predictive models using omic profiling data from patients with AIIDs.
  • Integration of diverse molecular data (genomics, proteomics, etc.) with AI algorithms.
  • In silico drug design and virtual patient efficacy prediction.

Main Results:

  • AI models confirm complex, multifactorial pathophysiology in AIIDs, involving shared inflammatory pathways.
  • Patient stratification based on molecular profiles enables targeted therapeutic approaches.
  • AI facilitates in silico drug candidate design and prediction of treatment response in virtual patients.

Conclusions:

  • AI-driven predictive models are crucial for advancing precision medicine in AIIDs.
  • These models improve patient stratification, mechanistic understanding, and personalized treatment strategies.
  • AI holds significant promise for optimizing drug discovery and efficacy prediction in managing AIIDs.